Evolent Health, Inc. (EVH)

4.60 +0.22% (+0.01)

Over 1Y: -52.3%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2.5 5 7.5 10
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Revenue: 479.5M Q3 '25 — Operating Cash Flow: 15.8M Q3 '25 — Free Cash Flow: 6.8M Q3 '25 — Net Income: -20.9M Q4 '25 — Revenue: 468.7M Q4 '25 — Operating Cash Flow: 48.8M Q4 '25 — Free Cash Flow: 41M Q4 '25 — Net Income: -429.1M Q1 '26 — Revenue: 496.2M Q1 '26 — Operating Cash Flow: -984K Q1 '26 — Free Cash Flow: -7.4M Q1 '26 — Net Income: -26.6M Q2 '26 — Revenue: 652.5M Q2 '26 — Operating Cash Flow: -9.3M Q2 '26 — Free Cash Flow: -16.2M Q2 '26 — Net Income: -28.4M -250M 0 250M 500M 750M
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.3
OE margin -0.89%
Oper. margin -20.4%
ROIC -27.4%
Accruals -28.4%
FCF margin 1.2%
EBITDA margin -15.1%
Gross margin 17.2%
OCF margin 2.6%
Profit margin -24.1%
ROA -25.6%
ROCE -28.9%
ROE -131.8%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.7
RPO / sales 0.005×
Segment HHI 0.58 HHI
RPO growth -55.6%

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.5
ND/EBITDA —
Quick ratio 1.2×
Cash / Debt 0.12×
F-score 5.0 pts
Debt / Eq 2.5×
Debt payback 35.0 yr
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.8
Sales CAGR 4Y +19.9%
Sales/sh Y/Y -4.1%
Sales Q/Q +46.9%
Shares change -0.41%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.